DrDavid Wingfield

I am PI for the UKDRI Minder Study in West London which offers smarthome sensor technology installed in patients’ homes to develop digital biomarkers which identify early signs of ill health and I am the Primary Care Principal Investigator for Imperial College in the International implementation study of blood biomarkers for the early and Accurate diagnosis of Alzheimer’s Disease (Davos Alzheimer’s Collaborative) and I am developing a research programme around identifying patients at high risk of Alzheimer’s disease and evaluating developing disease preventive. I also lead or co-lead numerous translational studies of technologybin clinical practice including in point of care testing in primary care, and developing a voice based biomarker for cognitive impairment in General Practice.